Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.52 |
| ▸ | RAB9A | P51151 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 3/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.47 |
| ▸ | CA9 | Q16790 | 3/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.47 |
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | KDM1A | O60341 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenformin SCHEMBL12487086 | 1.00 | NPC1 (0.52) | NPC1RAB9ASMN1; SMN2LMNATAAR1 | |
| Phenformin SCHEMBL15669213 | 0.98 | NPC1 (0.50) | NPC1RAB9ASMN1; SMN2LMNATAAR1 | |
| Phenformin SCHEMBL1560339 | 0.98 | RAB9A (0.50) | NPC1RAB9ASMN1; SMN2LMNATAAR1 | |
| Phenformin SCHEMBL210008 | 0.98 | NPC1 (0.50) | NPC1RAB9ASMN1; SMN2LMNATAAR1 | |
| Phenformin SCHEMBL3487197 | 0.98 | NPC1 (0.50) | NPC1RAB9ASMN1; SMN2LMNATAAR1 | |
| SCHEMBL18624768 | 0.97 | NPC1 (0.49) | NPC1RAB9ASMN1; SMN2LMNATAAR1 | |
| Phenformin SCHEMBL28415756 | 0.92 | ALDH1A1 (0.57) | NPC1RAB9ASMN1; SMN2LMNATAAR1 | |
| SCHEMBL7838315 | 0.90 | L3MBTL1 (0.51) | NPC1RAB9ATAAR1GAACYP2D6 | |
| Phenformin SCHEMBL11691594 | 0.89 | MEN1 (0.47) | NPC1RAB9ASMN1; SMN2TAAR1CA12 | |
| Phenformin SCHEMBL11697477 | 0.89 | MEN1 (0.47) | NPC1RAB9ASMN1; SMN2TAAR1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 19751 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079768-A | Method for selectively and efficiently depolymerizing and recycling PET in waste blended fabric | — | 2026-05-26 | — | — | CN | claimed |
| EP-4499765-B1 | COMPOSITIONS AND METHODS FOR TUNGSTEN ETCHING INHIBITION | BASF SE (DE) | 2026-05-06 | — | — | EP | claimed |
| EP-3956809-B1 | IMAGE PROCESSING METHOD FOR AN IDENTITY DOCUMENT | SURYS (FR) | 2026-05-06 | — | — | EP | claimed |
| US-12605354-B2 | Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions | NEW FRONTIER LABS, LLC (US) | 2026-04-21 | — | — | US | claimed |
| US-20260076969-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-03-19 | — | — | US | claimed |
| EP-4243366-B1 | NETWORK MONITORING AND TROUBLESHOOTING USING AUGMENTED REALITY | JUNIPER NETWORKS INC (US) | 2026-02-25 | — | — | EP | claimed |
| EP-4103445-B1 | SYSTEM AND METHOD FOR RAIL SCANNING USING ELECTROMAGNETIC ENGINES | HYPERLOOP TECH INC (US) | 2026-02-18 | — | — | EP | claimed |
| US-20260028334-A1 | N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER | WMT AG (DE) | 2026-01-29 | — | — | US | claimed |
| EP-4684799-A2 | ANTIBODIES THAT DISRUPT THE INTERACTION OF GAL3 AND INSULIN RECEPTOR OR INTEGRINS AND METHODS OF USE THEREOF | TrueBinding, Inc. (US) | 2026-01-28 | — | — | EP | claimed |
| US-20250360215-A1 | PHARMACEUTICAL COMBINATIONS AND METHODS FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES | YUH CHIOU HWA (US) | 2025-11-27 | — | — | US | claimed |
| EP-0004770-B1 | PHARMACEUTICAL AND DIETARY COMPOSITION COMPRISING GAMMA-LINOLENIC ACIDS | EFAMOL LIMITED (GB) | 1984-06-13 | — | — | EP | claimed |
| EP-0078434-A1 | Pharmaceutical and dietary compositions | EFAMOL LIMITED (GB) | 1983-05-11 | — | — | EP | claimed |
| US-4346709-A | Drug delivery devices comprising erodible polymer and erosion rate modifier | ALZA CORPORATION (US) | 1982-08-31 | — | — | US | claimed |
| US-4309415-A | LINOLENIC ACID OR DERIVATIVE WITH MATERIAL WHICH ENHANCES BIOSYNTHESIS OF THROMBOXANE A2 | VERRONMAY LIMITED (GB) | 1982-01-05 | — | — | US | claimed |
| EP-0037175-A1 | Pharmaceutical compositions | EFAMOL LIMITED (GB) | 1981-10-07 | — | — | EP | claimed |
| EP-0035856-A2 | Pharmaceutical and dietary compositions | EFAMOL LIMITED (GB) | 1981-09-16 | — | — | EP | claimed |
| US-4254109-A | INHIBIT LENS ALDOSE REDUCTASE | AYERST, MCKENNA & HARRISON INC. (CA) | 1981-03-03 | — | — | US | claimed |
| US-4254108-A | ALDOSE REDUCTASE INHIBITORS | AYERST, MCKENNA & HARRISON INC. (CA) | 1981-03-03 | — | — | US | claimed |
| EP-0019423-A1 | Pharmaceutical and dietary composition comprising gamma-linolenic acids | EFAMOL LIMITED (GB) | 1980-11-26 | — | — | EP | claimed |
| EP-0004770-A2 | Pharmaceutical and dietary composition comprising gamma-linolenic acids | EFAMOL LIMITED (GB) | 1979-10-17 | — | — | EP | claimed |